Skip to content
← Holders

BML Capital Management, LLC

What BML Capital Management, LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 1616824 · Filed Nov 6, 2026

Positions
20
Reported value
$187.6M
Opened
4
Closed
2
Other managers included
0

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Sep 30, 2025$109.2M
    20 positions
  2. Dec 31, 2025$115.7M
    16 positions
  3. Mar 31, 2026$155.8M
    16 positions
  4. Jun 30, 2026$176.1M
    18 positions
  5. Sep 30, 2026$187.6M
    20 positions
SecuritySharesChangeValueOf portfolio
ACRSAclaris Therapeutics, Inc.
11M−8.5%$57.6M30.7%
AVIRAtea Pharmaceuticals, Inc.
6.8M−2.9%$35.2M18.8%
ENGNenGene Therapeutics Inc.
6.7MNew$13.3M7.1%
PMVPPMV Pharmaceuticals, Inc.
7.3M+37.5%$12.2M6.5%
KHCKraft Heinz Co
475K+2.2%$10.8M5.8%
TLYSTilly's, Inc.
2.2M±0%$10M5.3%
KMXCarMax Inc
172.5K±0%$9.5M5.1%
OMOutset Medical, Inc.
2.5M±0%$7.6M4%
TGTTarget Corp
37.5K±0%$5.9M3.1%
SEERSeer, Inc.
2.2MNew$4.9M2.6%
TILInstil Bio, Inc.
645.6K±0%$4.7M2.5%
CNTBConnect Biopharma Holdings Ltd
3.9M+574.1%$4.3M2.3%
ORMPOramed Pharmaceuticals Inc.
884.4K+2.1%$4.1M2.2%
JANXJanux Therapeutics, Inc.
151.1K−2.5%$2.6M1.4%
PLRXPliant Therapeutics, Inc.
1.5M±0%$1.7M0.9%
LENZLENZ Therapeutics, Inc.
283.1KNew$1.1M0.6%
IMAImageneBio, Inc.
200.7K±0%$919.3K0.5%
TSLATesla, Inc.Put option
150−60.0%$696K0.4%
WMTWalmart Inc.Put option
335±0%$537.7K0.3%
KPTIKaryopharm Therapeutics Inc.
71.8KNew$87.6K0.1%